---
figid: PMC10528301__curroncol-30-00601-g003
pmcid: PMC10528301
image_filename: curroncol-30-00601-g003.jpg
figure_link: /pmc/articles/PMC10528301/figure/curroncol-30-00601-f003/
number: Figure 3
figure_title: ''
caption: Alternative promoters (tissue specific) and the downstream effects of CD133
  activation on the Akt pathway with implications for pluripotency, tumorigenesis,
  cell cycle effects, apoptosis and cell survival, protein synthesis, and angiogenesis
  based on IPA molecule activity prediction ((QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuitypathway-analysis)
  accessed on 24 July 2023) [].
article_title: An Overview of CD133 as a Functional Unit of Prognosis and Treatment
  Resistance in Glioblastoma.
citation: Thomas Joyce, et al. Curr Oncol. 2023 Sep;30(9):8278-8293.
year: '2023'

doi: 10.3390/curroncol30090601
journal_title: Current Oncology
journal_nlm_ta: Curr Oncol
publisher_name: MDPI

keywords:
- CD133
- stem cell marker
- glioblastoma
- chemo/radioresistance
- recurrence
- omics

---
